Mayo Clinic, Albert Einstein Medical School, Cleveland Clinic Foundation and Ford Institute Among Those Prescribing the Medication to Patients
This article was written in December 29, 2004 for migraineaid.com
Carla could feel a migraine coming on. It started with nausea and a sense of flashing lights behind her eyes. She knew it wouldn’t be long before the intense throbbing in her temple began. With reluctance she called in sick to work, knowing that her frequent absences due to migraines would affect her chances for promotion.
Carla had tried all the prescription and over-the-counter migraine remedies, and nothing had worked well. She knew they wouldn’t this time either. So she did the only thing she ever could do when the migraine hit full force. She returned to bed and lay in her darkened room, waiting for the pain to pass.
Over 25 Million Americans Suffer from Migraines
Carla’s situation is not unique. In fact, she is one of an estimated 25 million Americans who suffer from debilitating migraine headaches. For migraine sufferers the symptoms can include partial vision loss, nausea, a pounding in the head or jaw, sensitivity to light and noise, and an inability to function at work and home. Migraine headaches cost the United States economy over $11 billion each in terms of lost workdays, according to an article in Archives of Internal Medicine (1999).
Conventional drugs prescribed by physicians for migraines can sometimes alleviate the symptoms, however they rarely eliminate them completely and are effective only on some patients. Furthermore, they can be addictive and often cause serious side effects such as depression, weight gain and hair loss.
New Treatment Focuses on Migraine Prevention
A new option now offers migraine sufferers a preventive solution. Petadolex Butterbur Gelcaps, manufactured by the well-respected German pharmaceutical company Weber & Weber, has been a medication prescribed by doctors throughout Europe for over 30 years. Only recently has it become available in the U.S. It can be purchased without a prescription at most independent health food stores and on the Internet. An all-natural medication made from the Butterbur plant, it is taken prophylacticly to prevent migraines.
Steven Silberstein, MD Professor of Neurology at Thomas Jefferson Hospital in Philadelphia stated, “From a cost point of view, preventive therapy is actually a cost benefit.” Patients save an average of $1,321.27 per year when using preventive medications like Petadolex Butterbur Gelcaps for migraines versus acute prescription medications for migraine episodes. Outpatient visits for migraine treatment declined by 51 percent and emergency room visits decreased by 82 percent when patients took preventive medication for their migraines, according to Headache magazine (2003).
Taken prophylactically, Petadolex Butterbur Gelcaps costs $41-$74 per month for the average migraine sufferer. Other migraine medications average $118-$159 per month.
The Clinical Data is Compelling
Patients who took Petadolex Butterbur Gelcaps for a minimum of two weeks noticed a lesser frequency of migraines and a reduction in pain intensity when they did get a headache. In a double-blind study published in Neurology (2004), researchers gave migraine sufferers a daily dose (100 mg or 150 mg) of Petadolex Butterbur Gelcaps or a placebo for 16 weeks. Seventy-one percent of the patients on the higher dose reduced the number of migraines and the severity of migraines they did get by at least 50 percent.
In a double-blind study published in the European Journal of Neurology (2004), 60 patients with migraines took 50 mg of Petadolex Butterbur Gelcaps or a placebo twice daily. The Petadolex Butterbur Gelcaps group had 62 percent fewer migraine days than usual after just 12 weeks, while the placebo group dropped only 20 percent.
Both studies were carried out in strict accordance with standards established by the International Headache Society and Good Clinical Practice. Furthermore, it was found that Petadolex Butterbur Gelcaps was well tolerated and safe. The most frequent side effects reported were mild gastrointestinal events (burping, mild stomach pressure but no gastritis), Headache (2003), and no known drug interactions have been found.
Petadolex Butterbur Gelcaps Gains Support from Major Hospitals and Physicians
Many highly-regarded institutes have begun recommending Petadolex Butterbur Gelcaps to their patients. Among them are the Mayo Clinic, Cleveland Clinic Foundation, Albert Einstein Medical School and the Ford Institute.
Richard Lipton, MD, Professor of Neurology at Albert Einstein Medical School and past-President of the American Headache Society, a leading U.S. neurological group, said that the early research looked very encouraging. “Petadolex Butterbur Gelcaps is a promising new preventive strategy for migraine sufferers,” he said.
Mark Stillman, MD, at Cleveland Clinic Foundation said, “Studies of preventive medication are lacking. Recent studies of Petadolex Butterbur Gelcaps demonstrate it to be a promising addition to the preventive management of migraine headaches.”
Widely Available Without a Prescription
Because Petadolex Butterbur Gelcaps is a non-prescription medication here in the U.S., it is available in GNC, Vitamin World Stores, independent health food stores, on the Internet and directly from the manufacturer. Weber & Weber, is a highly-respected, German-based international pharmaceutical company founded in 1953. For more information on Petadolex Butterbur Gelcaps and Weber & Weber